Brief: Suven Pharmaceuticals Executed Definitive Agreements For Acquiring 100% Of Shares In Sapala Organics
June 13 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* EXECUTED DEFINITIVE AGREEMENTS FOR ACQUIRING 100% OF
SHARES IN
SAPALA ORGANICS
* DEAL FOR 2.3 BILLION RUPEES
* CO AGREED TO INITIALLY ACQUIRE 67.5% BY WAY OF SECONDARY
TRANSFER FROM SAPALA ORGANICS EXISTING SHAREHOLDERS
Source text for Eikon: ID:nBSE3qYcqh
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss